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Abstract
It has been suggested that mitochondrial dysfunction plays a role in metabolic disorders including obesity, diabetes, and
hypertension. The fact that mitochondrial defects can be accumulated over time as a normal part of aging may explain why
some individuals can eat all sorts of foods and remain at normal weight while they are young. However, around the fourth
decade of life there is a trend towards ‘‘middle-age spread’’ with weight gain and the body’s decreasing ability to
metabolize calories efficiently. To test the hypothesis that mitochondrial variants are associated with BMI in adults, we
analyzed a total number of 984 mitochondrial single nucleotide polymorphisms (mtSNPs) in a sample of 6,528 individuals
participating in the KORA studies. To assess mtSNP association while taking heteroplasmy into account we used the raw
signal intensity values measured on the microarray and applied linear regression. Significant results were obtained for 2
mtSNPs located in the Cytochrome c oxidase subunit genes (MT-CO1: Padjusted = 0.0140 and MT-CO3: Padjusted = 0.0286) and 3
mtSNPs located in the NADH dehydrogenase subunit genes (MT-ND1, MT-ND2 and MT-ND4L: Padjusted = 0.0286).
Polymorphisms located in the MT-CO3 and MT-ND4L genes have not been associated with BMI or related phenotypes in
the past. Our results highlight the importance of the mitochondrial genome among the factors that contribute to the risk of
high BMI. Focusing on mitochondrial variants may lead to further insights regarding effects of existing medications, or even
to the development of innovative treatments.
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Introduction
Excess of weight is a major risk factor for mortality and
morbidity from cardiovascular disease [1], type 2 diabetes [2], and
incident cancer [3]. Three million deaths per year worldwide are
attributed to overweight and obesity in total [4]. Obesity is a
medical condition in which excess body fat has accumulated to the
extent that it may have an adverse effect on health [5]. Anyway,
the conflation of lean and fat body mass becomes inconsistent in
the elderly with both muscle mass and strength begining to decline
as part of aging [6]. Changes such as accumulation of intra- and
extra-myocellular lipids, improper folding of structural and
contractile proteins, and mitochondrial dysfunction are thought
to occur with age [7–9]. Dysfunctional mitochondria are thought
to play a key role in function decline with aging, as the
mitochondria are the main producers of both cellular energy
and free radicals.
Mitochondria are membrane-bound organelles found in the
cytoplasm of almost all eukaryotic cells. Their primary function is
to generate large quantities of energy in the form of adenosine
triphosphate (ATP). In the early 1960s it was discovered that
mitochondria contain their own DNA (mtDNA) of approximately
16.6 kb. It is known to code for 13 subunits of the mitochondrial
respiratory chain complexes, 2 ribosomal (rRNA) genes, and 22
transfer RNA (tRNA) genes that are required for mitochondrial
protein synthesis. Mitochondria consume oxygen and substrates to
generate the vast majority of ATP while producing reactive
oxygen species (ROS), also known as free radicals, in the process.
An excess of ROS may damage DNA, proteins, and lipids if not
rapidly quenched. This damage is termed oxidative stress. It has
been recently recognized that oxidative stress is increased (ROS
overproduction) in obesity [10,11] and in fat accumulation in
adipocytes [12]. The 13 structural genes are essential for energy
production through the process of oxidative phosphorylation
PLOS ONE | www.plosone.org 1 August 2014 | Volume 9 | Issue 8 | e105116
(OXPHOS) and generation of ATP. The activity of the OXPHOS
system that consists of five enzyme complexes (I–V) can be affected
by a number of factors including age and physical training [13]. In
addition to supplying ATP and involvement in oxidative stress,
mitochondria also participate in other cellular processes, including
signal transduction, cell cycle regulation, thermogenesis, and
apoptosis. mtDNA is maternally inherited and lacks recombina-
tion [14]. One major difference between mtDNA and nuclear
DNA (nDNA), which is relevant for the understanding of human
diseases, is the heteroplasmy effect, which was originally believed to
be a rare phenomenon. Because a cell carries many mitochondria,
and also the mitochondrial genome has a higher mutation rate
than the nuclear genome, there is heterogeneity of the relative
frequency of a mtDNA variant within an individual tissue, cell,
and even within the same mitochondrion. Therefore, mitochon-
dria are considered heteroplasmic. The clinical expression of some
phenotypes is determined by the relative proportion of normal and
mutant mitochondrial genomes in different tissues. Mutations of
mtDNA are under a growing scientific spotlight and there is
increasing evidence that these mutations play a central role in
many, if not most, human diseases.
In the past years, genome-wide association studies (GWASs)
have identified over 90 common genetic variants associated with
BMI in adult samples [15–19]. A growing body of research is
demonstrating that altered mitochondrial energy production is a
major anomaly capable of setting off a chain of metabolic events
leading to obesity [20–23]. It has also been suggested that
particular mtDNA haplogroups might be associated with ineffi-
cient energy expenditure [24] and obesity [25]. A mtDNA
haplogroup is a collection of mtSNPs at certain genetic loci
accumulated throughout human history that could be attributed to
genetic drift and/or climate selection [26]. The fact that
mitochondrial defects can be accumulated over time as a normal
part of aging may explain why some individuals can eat all sorts of
foods and remain at normal weight while they are young.
However, around the fourth decade of life there is a trend towards
‘‘middle-age spread’’ with weight gain and the body’s decreasing
ability to metabolize calories efficiently. In two newly published
studies in animals, researchers show how the dynamics of the
mitochondria play a key role in the body’s ability to control weight
gain [27,28]. Hence, whether one becomes obese or remains lean
can depend on the dynamics of the mitochondria, the body’s
energy-producing ‘‘battery’’.
The purpose of the current study was to conduct a mitochon-
drial GWAS to identify genetic variants influencing BMI. In
particular, we tested 984 mtSNPs in a sample of 6,528 adults, aged
24–85 years.
Results
We performed mitochondrial genome wide association analysis
separately for each genotyping chip and corresponding sample (see
Table 1). After QC, a total number of 984 mtSNPs were included
in the analysis. To assess mtSNP association while taking
heteroplasmy into account, we used the raw signal intensity values
that were measured on the microarray and applied the linear
regression method as described in the Materials and Methods
section. The resulting p-values after adjustment for multiple testing
are plotted in Figure 1 for each genotyping chip. The x-axis
represents the mitochondrial genome, showing the position and
relative size of each of the 13 major mitochondrial genes.
Four and one mtSNPs were significant for Affymetrix 6.0 and
Illumina Exome chip, respectively. No significant mtSNPs were
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results that remained significant after adjustment for multiple testing
(Padjusted#0.05) are presented in Table 2. The two most significant
mtSNPs associated with BMI are located in the Cytochrome c oxidase 1
and 3 (MT-CO1mt6663ARG and MT-CO3mt9698TRC) genes of
complex IV, with associated adjusted p-values of 0.014 and 0.029,
respectively. Another three locations of NADH subunit dehydrogenase
genes of complex I were also significant (MT-ND1mt3336TRG:
Padjusted = 0.029; MT-ND2mt4851CRT: Padjusted = 0.029; MT-
ND4Lmt10550ARG: Padjusted = 0.029). In all significant mtSNPs the
estimates of bsex and bage were significant and positive, indicating a
significantly higher BMI in males and with older age. All five
significant mtSNPs were present only on one chip without
overlapping, i.e., they were not shared by the other chips.
A negative parameter estimate for the mtSNP (bSNP,0)
indicates that the risk allele is the minor allele while a bSNP.0
indicates that the risk allele is the major allele. Taking the most
strongly associated variant mt6663ARG in the MT-CO1 gene,
based on our estimate (bmt6663ARG = 20.5560.1) BMI increases
when the ratio of alleles A and G decreases, i.e., an increase in
heteroplamy with the G allele at this locus leads to an increased
BMI. The same applies to the other mtSNPs; e.g. having
mt10550ARG heteroplasmy with more G than A alleles results
in a higher BMI than having only A alleles. The estimates of the
model parameters for each significant mtSNP are provided in
Table S1.
Discussion
Excess of weight is a medical condition in which excess body fat
has accumulated to the extent that it may have an adverse effect
on health, leading to reduced life expectancy and/or increased
health problems. The possible role of mitochondria in the
development of obesity is mainly concerned with the efficacy of
mitochondrial energy provision [29,30]. Apparently, the balance
Figure 1. Mitochondrial genome-wide P values after adjusting for multiple testing. On the y axis, adjusted p-values transformed into the
negative of the base 10 logarithm, 2log10(p-value), are shown. The x-axis represents the mitochondrial genome, displaying the position and relative
size of each of the 13 major mitochondrial genes, 12S and 16S rRNAs, hypervariable region 1 (HVRI), hypervariable region 2 (HVR II) as well as the
position of the 22 tRNAs (gray). The dashed lines show the critical values of the pointwise significance level corresponding to an FDR of 0.05.
doi:10.1371/journal.pone.0105116.g001
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between energy conservation into the ATP molecule and energy
dissipation in the form of heat loss thus represents the key
metabolic control, which is crucial for possible development of
obesity. Obesity, as well as fat accumulation in adipocytes, has
been related to an increased ROS production in human
mitochondria [10–12]. In the current study, in which we
examined association between BMI and mtSNPs, we identified
two mtSNPs (mt6663ARG, mt9698TRC) located in Cytochrome
c oxidase subunits (MT-CO1 and MT-CO3) and three mtSNPs
(mt3336TRG, mt4851CRT, mt10550ARG) located in NADH
subunits (MT-ND1, MT-ND2, and MT-ND4L), that were
significantly associated with BMI after adjusting for multiple
testing. Although mtDNA is transmitted from mother to offspring
unchanged (lack of recombination), due to the higher mutation
rate in mtDNA compared to nDNA, many mutations have
occurred only recently rather than many generations ago, and
even in the current generation. For that reason pairwise LD is
reduced, and when one mtSNP is significant it is not expected that
the neighboring mtSNPs are also significant.
MT-CO1mt6663ARG and MT-CO3mt9698TRC
Mitochondrially encoded cytochrome c oxidase sub-
units, complex IV, is a key oxidative enzyme regarded as one of
the major regulation sites for the OXPHOS system, controlled by
both nDNA and mtDNA. Its catalytic activity is primarily
determined by 3 of the 13 subunits which are encoded by the
mtDNA (MT-CO1, MT-CO2, and MT-CO3) [31]. The loss of
function of this enzyme has been suggested to trigger ROS
production, although the increase in radical accumulation rests not
with the ETC but with non-mitochondrial sources [32]. However,
the function of each subunit and the molecular mechanism behind
the regulation on the activity of this important protein complex are
largely unknown [33]. The interesting finding that suppression of
cytochrome c oxidase activity also sensitizes cells to death signals
[33] could shed some light on the role of defective cytochrome c
oxidase in aging and age-related diseases as an increase of BMI
with age.
MT-ND1mt3336TRG, MT-ND2mt4851CRT, and MT-
ND4Lmt10550ARG
Mitochondrially encoded NADH dehydrogenase sub-
unit genes, complex I, is the first enzyme in the mitochondrial
respiratory chain. It extracts energy from NADH, produced by the
oxidation of sugars and fats, and traps the energy in a potential
difference or voltage across the mitochondrial inner membrane.
The potential difference is used to power the synthesis of ATP.
Because NADH dehydrogenase is central to energy production in
the cell, its malfunction may result in a wide range of metabolic
disorders. Some of them are due to mutations in the mitochondrial
genome, while others, which result from a decrease in the activity
of complex I, or an increase in the production of ROS, are not yet
well understood.
MT-ND1 and MT-ND2 genes were previously reported to be
related with body fat mass and intramuscular fat in animals
[23,34,35]. The significant findings in our study at mt3336TRG
(MT-ND1) and mt4851CRT (MT-ND2) have associated effect
sizes estimated to be 20.23 and 21.11, respectively. In other
words, increasing the number of T alleles (or decreasing G alleles)
at mt3336 in an individual will help to reduce the BMI, while
increasing the number of T alleles (or decreasing C alleles) at
mt4851 will contribute to increase BMI. In this study we identified
for the first time a significant association between MT-ND4L
(mt10550ARG) and BMI, with an estimated effect size of 20.31.
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values, i.e., people with heteroplasmy having a large number of G
alleles will have a higher BMI than people with a smaller number
of G alleles. MT-ND4L is one of the 7 mtDNA-encoded subunits
included among the approximately 41 polypeptides of respiratory
complex I. MT-ND4L is probably a component of the hydropho-
bic protein fragment of the complex [36].
While associations of the MT-CO1 gene with intramuscular fat
in animals have been reported [35], no significant findings have
been reported so far for the MT-CO3 gene with BMI, nor with
other BMI-related phenotypes. Liu et al. [37] suggested an effect
of mtSNPs, including MT-CO2, MT-ND1, and MT-ND2 genes,
on BMI but this effect failed to reach significance after adjusting
for multiple testing. Similarly, Saxena et al. [38] detected nominal
signals of association between BMI and mtSNPs, including MT-
ND1, MT-ND2, and MT-ND3 genes; however after adjusting for
multiple testing these associations disappeared.
Recently, Knoll et al., 2014 [39] did not find association
between mtSNPs and obesity in children. However, this may be
because heteroplasmy was not included in their study or different
mtSNPs might be relevant for children than adults with regard to
BMI.
Two of the significant variants MT-ND1mt3336TRG and MT-
CO1mt6663ARG are missense mutations which lead to an amino
acid change, thus being a non-synonymous variant. So, individuals
with an excess of missense mutations may carry an appreciable
fraction of an altered protein that is responsible for an elevated
BMI. The other three significant variants MT-ND2mt4851CRT,
MT-CO3mt9698TRC, and MT-ND4Lmt10550ARG are synonymous
mutations, i.e., they code for the same amino acid. How an excess
of synonymous mutations at these loci could impact BMI needs
further investigation, since the single nucleotide change leads to an
unchanged protein. However, different codons might lead to
differential protein expression levels. Two of the synonymous
variants, mt9698C and mt10550G, are present in the European
mtDNA haplogroups U8 and K, respectively. However, to date
only haplogroup T has been suggested as a risk factor for obesity
[24].
These results together with previously published findings suggest
that genetic variation in NADH dehydrogenase and cytochrome c
is a risk factor for several metabolic disorders, including BMI and
BMI-related phenotypes. Multiple lines of evidence suggest that
mitochondrial dysfunction as well as altered mitochondrial
genome expression, particularly of genes encoding complex I–IV
may play a role in BMI. Searching for previous suggested
candidate mtSNPs associated with BMI or related phenotypes has
yielded a small number of positive findings, possibly due to low
sample sizes or the lack of taking heteroplasmy into account in the
analysis. In this study we have considered the heteroplasmy effect
and found mtSNPs in candidate gene regions to be significantly
associated with BMI that previously were suggested to be
implicated in obesity, body fat mass, or intramuscular fat (MT-
ND1, MT-ND2, and MT-CO1). In addition, two novel suscep-
tibility mtSNPs in the MT-ND4L and in the MT-CO3 regions
have been identified. In both polymorphisms heteroplasmic
individuals towards a larger number of the respective minor allele
increases the risk of developing a high BMI.
The regression models for all significant mtSNPs identified in
this study also corroborate the generally acknowledged fact that
males have slightly but significant higher BMI values than females
and BMI also increases significantly with older age. With repond
to sex, this effect is to be expected due to the fact that adult males
and females with the same BMI are classified identically in regard
to whether their weight is normal. However, even though men
may have slightly higher BMI values than women, this does not
necessarily mean that they are more overweight. For instance,
women typically have more body fat than men, whereas men
typically have more muscle than women, and muscle has a much
greater density (it takes up less volume than an equal mass of fat).
It is also known that BMI is largely influenced by age in adults
[40,41]. It has been suggested that BMI increases linearly with age
in women, but in men it increases with age in two stages – a more
intensive rise between age 20–40 and a much slower increase
between age 40–60 [42]. High BMI can occur at any age, but with
both muscle mass and strength beginning to decline around the
age of 40, an increased BMI at this age may be related to
mitochondrial dysfunction.
Conclusion
In summary, our study reports genetic variants located in the
cytochrome c subunits 1, 3, and in the NADH dehydrogenase
subunits 1, 2, and 4L of the mtDNA that are significantly
associated with BMI in adults. Heteroplasmy in these variants
towards the minor allele increases the risk of developing high BMI.
Based on these findings we hypothesize that common metabolic
diseases as obesity or high BMI are attributable at least in part to
mitochondrial polymorphisms. Animal and human data consis-
tently show that mitochondria are altered in aging, leading to
increased mutations in mtDNA, decreased expression of some
mitochondrial proteins, reduced enzyme activity, and altered
respiration with reduced maximal capacity in sedentary adults.
Since the primary role of mitochondria is to produce ATP to
maintain the energy status of the cell, shifts in respiratory activity
and capacity can lower the membrane potential, reduce cellular
ATP concentration, and signal cellular apoptotic events. Increased
apoptosis without correspondingly increased protein synthesis will
eventually lead to net muscle fiber loss. All of these factors are
likely to contribute to age-associated BMI, and mounting evidence
suggests that most of these age-related changes can be either
prevented or attenuated through increased physical activity. There
are some thoughts that the accumulation of oxidative damage
caused by long-term ROS production is responsible for these
changes with age. Cytochrome c and NADH dehydrogenase
complexes are both involved in the regulation of mitochondrial
ROS. Indeed, blocking ROS formation in animals by the targeted
expression of antioxidant enzymes ameliorates age-associated
dysfunction and returns mitochondrial parameters to those of
young animals [43]. Whether this is also true for humans remains
to be shown. However, behavioral factors that may improve
mitochondrial function and BMI control, such as physical activity
and caloric restriction, also reduce ROS production and increase
antioxidant defenses. Although physical activity training in elderly
adults probably does not completely reverse the primary effects of
aging, it may clearly reduce the rate of mitochondrial decline and
attenuate the aging processes [44].
These findings highlight the important role of the mtDNA
among the factors that contribute to the risk of high BMI in adults
and suggest that variants in the mitochondrial genome may be
more important than has previously been suspected. Therefore, a
challenge for possible novel therapeutic strategies might be the
further elucidation of intracellular ROS signaling pathways for
effective therapeutic gain.
Materials and Methods
Study design and population
The Cooperative Health Research in the Region of Augsburg
(KORA) study is a series of independent population-based
mtSNPs Associated with BMI in Adults
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epidemiological surveys and follow-up studies of participants living
in the region of Augsburg, in southern Germany, in a mixed urban
and rural area with demographic and socioeconomic character-
istics roughly reflecting those of an average central European
population. All participants are residents of German nationality
identified through the registration office and written informed
consent was obtained from each participant [45]. The study was
approved by the local ethics committee (Bayerische Landesärzte-
kammer). All participants filled in a self-administrated question-
naire and underwent a standardized personal interview and an
extensive medical examination. The study design, sampling
method, and data collection have been described in detail
elsewhere [46]. The most recent KORA studies are KORA S4
(1999–2001) with its follow-up KORA F4 (2006–2008) and
KORA S3 (1994–1995) with its follow-up KORA F3 (2004–
2005). The present study includes data of the studies F3, F4, and
additionally from those individuals of S4 that did not participate in
F4, including a total number of 6,528 unrelated individuals. In
order to avoid confounding with insulin-dependent diabetes
mellitus, 247 individuals diagnosed as diabetic were not included
in the study.
BMI phenotype
The body mass index (BMI), or Quetelet index (devised between
1830 and 1850 by the Belgian polymath Adolphe Quetelet), is a
measure for human body shape defined as the individual’s body
weight divided by the square of the height (kg/m2). All participants
were subjected to several medical examinations including BMI
measurement.
Genotyping
DNA was extracted from full blood after the blood draw and
then stored at 280uC. Genotyping was performed using different
platforms such as the Affymetrix 6.0 GeneChip array (KORA F4),
Illumina MetaboChip 200K (KORA F3 and F4), Illumina Human
Exome Beadchip array (KORA F4), and Affymetrix Axiom chip
array (KORA S4 and F4). A total number of 6,528 individuals
were genotyped. Some individuals of KORA F4 were present on
more than one chip, some of them (1,549) were included on all
chips. Only single-nucleotide polymorphisms located in the
mitochondrial genome (mtSNPs) were considered in this study.
Genotyping data and samples are summarized in Table 3. Most of
the covered mtSNPs have distinct positions identified by different
chips. Although the Affymetrix 6.0 is the one containing the largest
number of mtSNPs some regions are not well covered. The
Illumina Metabochip contains the smallest number of mtSNPs and
many regions are uncovered, especially the hypervariable regions
(HVRI and HVRII) as well as the CO1 and CO2 genes. However,
when all chips are considered together, good overall coverage of
the mitochondrial genome is obtained (Figure 2).
Genotype calling
Current SNP microarrays are able to genotype more than a
million SNPs simultaneously. There are some statistical issues such
as the normalization of raw intensities, background correction,
outlier detection, and allele calling (genotyping) that are shared
between different microarray platforms irrespective of chip
technology and design principles. The most commonly used
platforms, Affymetrix and Illumina, represent a SNP by a number
of probes (Affymetrix) or beads (Illumina) for each of the two
alleles. The probes/beads have different affinities, depending on
the DNA sequence they target. A first step in many algorithms for
genotyping is to cluster the probe intensities for each allele and
SNP, and in a second step to make a call based on the clustered
intensities.
The allele frequency, one of the most important population
indices used in genetics, denotes the relative frequency of a certain
allele at a marker locus. There are two kinds of allele frequencies:
individual-level that represents the within-individual relative
frequency of alleles and its standard error reflects inter-cell
variability in an individual, and population-level that refers to the
within-population relative frequency of alleles and its standard
error reflects inter-individual variability in a population [47].
Using SNPs, both individual and population allele frequencies can
be estimated using an allele counting approach (genotype-based)
and using an intensity measuring approach (intensity based). A
problem arises, however, when dealing with mtSNPs due to the
heteroplasmy effect, causing heterogeneous mtDNA in the sense
that different mitochondria can have different genotypes, such that
a genotype at an mtDNA locus may not be restricted to 0, 1, or 2
minor alleles. This issue affects the possibility of estimating
genotypes and makes calling algorithms useless. Therefore,
whenever one intends to identify susceptibility genes located in
the mtDNA we recommend accounting for heteroplasmy using
individual-level allele frequencies obtained from the intensity
values.
Quality control
First a visual check was performed plotting the intensity
measures of each mtSNP separately for each chip. In this step
only the Axiom chip displayed anomalies in some intensity values.
There seems to be an upper bound for the intensity values at an
intensity of 4095. As a result some mtSNPs had a significant
fraction of either their A or B intensities squeezed into the region
just below that upper bound; apparently without the bound those
intensities would have taken higher values. Since intensities close
to the cut-off value of 4095 cannot be trusted, we proceeded as
described in the Text S1.
After the visual check, normalization of microarray data and
outlier corrections were performed separately for each chip as
Table 3. Distribution of characteristics of the study population.
Chip mtSNP KORA Individuals (Males/Females) Mean age Males/Females Mean BMI Males/Females
Affy. 6.0 465 F4 1646 (788/858) 60.468.8/60.168.7 28.264.3/27.564.9
Affy. Axiom 252 S4/F4 3530 (1702/1828) 54.1614.2/53.6613.9 27.764.2/26.965.1
Illum. Exome 226 F4 2721 (1294/1427) 55.5613.2/54.8613.1 27.764.0/26.965.1
Illum. Metabochip 135 F3 2889 (1393/1496) 56.6612.9/56.1612.5 27.863.7/27.065.0
F4 2817 (1338/1479) 55.5613.2/54.9613.1 27.764.1/27.065.1
The mtSNPs column shows the number of mitochondrial SNPs provided by each chip. Distributions are presented as means 6 standard deviation.
doi:10.1371/journal.pone.0105116.t003
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described in Text S1. A summary of the quality control results is
given in Table 1.
Statistical methods
To approach the heteroplasmy present in the mitochondria we
used the raw signals of luminous intensity, where every measure-
ment is associated with a specific mtSNP and represents one of its
alleles [48,49]. The number of measures n per mtSNP depends on
the vendor-specific technology employed on the genotyping chip.
At the very least there have to be two signals, one for each of the
two alleles. Often, however, the chip design includes more than
one measurement per SNP and allele. That is, for every individual
and SNP we have intensity measurements (A1, B1), …, (An, Bn)
with n. = 1 where Ai and Bi represent the intensities of the two
alleles A and B. The best way to assess the association of BMI with
the mtSNP intensities at a given age is to apply linear regression
analysis using BMI as quantitative response variable. The mtSNP
enters the model as a covariate via the log2-transformed intensity
ratio, log2( A/B), where A and B denote the mean intensity, or
single measure in case of n = 1, for the A allele and B allele,
respectively. To improve the convergence properties of the model
estimates we center this variable (z = log2( A/B)2m) as well as the
additional quantitative covariate age at examination, i.e., the age
at the time that the mtSNPs and BMI were measured. Sex is also
introduced in the model as a covariate. The linear regression
model for the ith-mtSNP is:
BMIj~b0zb1zijzb2agejzb3sexjzeij for j~1 . . . m
where j denotes the individual and m is the sample size. The aim of
this study is to evaluate how BMI is influenced by mitochondrial
variants taking into account the age for a particular person on the
phenotype BMI, and therefore the model adjusts for individual age
differences in the study population. Using this model it is not
possible to make any claims based on the effect of age on
heteroplasmy at the particular mtSNP. However, due to the
adjustment by age on BMI in the model, we can be sure that in
case of positive findings the BMI change is in fact caused by
variations of heteroplasmy at the particular mtSNP, and not by
differences in age that jointly influence BMI and heteroplasmy,
without an effect of heteroplasmy on BMI.
P-values were obtained from the Wald test, which is based on
the asymptotic normality of the regression coefficient estimates,
and corrected for multiple comparisons applying the Benjamini-
Hochberg false discovery rate (FDR) using the R function p.adjust
[50]. The resulting adjusted P-values are also known as ‘‘Q-
values’’. Each type of genotyping chip needs to be analyzed
separately because different chips make use of different technol-
ogies, even between chips of the same manufacturer. The two
Affymetrix chips, Affy6.0 and Axiom, share 170 positions and
Illumina chips, Exome and Metabochip, share 44 positions. Only
9 positions are common to all four chips. Overlapping mtSNPs
were analysed separately for each respective genotyping chip,
giving in this way the opportunity of validation in the case of
significant results. All the analyses were performed with the R
statistical software [51].
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